- Home
- IBIO vs IINN Comparison
IBIO vs IINN Comparison
Compare IBIO & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBIO | IINN |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 35.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IBIO | IINN |
|---|---|---|
| Price | $1.84 | $0.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $4.00 | $2.00 |
| AVG Volume (30 Days) | ★ 13.3M | 149.9K |
| Earning Date | 02-09-2026 | 10-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.11 | $2,582.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 185.71 | N/A |
| 52 Week Low | $0.56 | $0.40 |
| 52 Week High | $6.89 | $1.65 |
Technical Indicators
Market Signals| Indicator | IBIO | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 38.00 |
| Support Level | $1.86 | $0.99 |
| Resistance Level | $2.14 | $1.18 |
| Average True Range (ATR) | 0.44 | 0.06 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 26.79 | 2.56 |
Price Performance
Historical ComparisonAbout IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.